Immune Reconstitution Therapy or Continuous Immunosuppression for the Management of Active Relapsing–Remitting Multiple Sclerosis Patients? A Narrative Review

by Isa Ahmed AlSharoqi, Mohamed Aljumah, Saeed Bohlega, Cavit Boz, Abdelkader Daif, Salam El-Koussa, Jihad Inshasi, Murat Kurtuncu, Thomas Müller, Chris Retief, Mohammad Ali Sahraian, Vahid Shaygannejad, Ilham Slassi, Karim Taha, Magd Zakaria, Per Soelberg Sørensen
Published 2020-04-01